US recommends Johnson & Johnson vaccine hiatus after clot reports

The United States recommends a pause in the administration of the single dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.

In a joint statement Tuesday, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) said they were investigating clots in six women in the days following vaccination in combination with a reduction in the number. platelets. Over 68 million doses of the JJ vaccine have been administered in the United States.

U.S. federal distribution channels, including mass vaccination sites, will suspend use of the JJ vaccine, and states and other suppliers are expected to follow suit.

The CDC’s advisory committee on immunization practices will meet on Wednesday to discuss the cases and the FDA has also launched an investigation into the cases.

“Until this process is complete, we recommend a pause in the use of this vaccine as a precaution,” said Dr Anne Schuchat, CDC Senior Deputy Director and Dr Peter Marks, Director of the Assessment Center. and FDA Biologics Research. in a joint statement.